These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2058394)

  • 1. Noonan's syndrome: abnormalities of the growth hormone/IGF-I axis and the response to treatment with human biosynthetic growth hormone.
    Ahmed ML; Foot AB; Edge JA; Lamkin VA; Savage MO; Dunger DB
    Acta Paediatr Scand; 1991 Apr; 80(4):446-50. PubMed ID: 2058394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment.
    Noordam C; van der Burgt I; Sweep CG; Delemarre-van de Waal HA; Sengers RC; Otten BJ
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):53-9. PubMed ID: 11167926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
    Cotterill AM; McKenna WJ; Brady AF; Sharland M; Elsawi M; Yamada M; Camacho-Hübner C; Kelnar CJ; Dunger DB; Patton MA; Savage MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2291-7. PubMed ID: 8964866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD; Blethen SL; Sy JP; Veldhuis JD
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
    de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced human growth hormone (hGH) bioactivity without a defect of the GH-1 gene in three patients with rhGH responsive growth failure.
    Binder G; Benz MR; Elmlinger M; Pflaum CD; Strasburger CJ; Ranke MB
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):89-95. PubMed ID: 10468970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium-phosphate metabolism and bone markers in two patients with Noonan's syndrome treated with growth hormone].
    Praticò G; Palano GM; Lo Presti D; Parisi G; Caruso-Nicoletti M
    Minerva Pediatr; 2003 Dec; 55(6):593-8. PubMed ID: 14676730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment in children with Noonan's syndrome: four year results of a partly controlled trial.
    Noordam C; Van der Burgt I; Sengers RC; Delemarre-van de Waal HA; Otten BJ
    Acta Paediatr; 2001 Aug; 90(8):889-94. PubMed ID: 11529537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.
    Blair JC; Camacho-Hübner C; Miraki Moud F; Rosberg S; Burren C; Lim S; Clayton PE; Bjarnason R; Albertsson-Wikland K; Savage MO
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):163-8; discussion 161-2. PubMed ID: 14725676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy in Noonan's syndrome: non-cardiomyopathic congenital heart disease does not adversely affect growth improvement.
    Brown DC; Macfarlane CE; McKenna WJ; Patton MA; Dunger DB; Savage MO; Kelnar CJ
    J Pediatr Endocrinol Metab; 2002 Jun; 15(6):851-2. PubMed ID: 12099396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
    Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with growth hormone in Noonan's syndrome.
    Thomas BC; Stanhope R
    Acta Paediatr; 1993 Oct; 82(10):853-5. PubMed ID: 8241645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
    Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up.
    MacFarlane CE; Brown DC; Johnston LB; Patton MA; Dunger DB; Savage MO; McKenna WJ; Kelnar CJ
    J Clin Endocrinol Metab; 2001 May; 86(5):1953-6. PubMed ID: 11344190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.
    Pihoker C; Badger TM; Reynolds GA; Bowers CY
    J Endocrinol; 1997 Oct; 155(1):79-86. PubMed ID: 9390009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.